Skip to content

Screener

Eligibility screening

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Recept…

Sponsored by Seattle Children's HospitalStudy detailsClinicalTrials.gov

1 US site in WA

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.